Mechanisms of antibiotic resistance

11,158views

Mechanisms of antibiotic resistance

Watch later

Watch later

Atrophy, aplasia, and hypoplasia
Metaplasia and dysplasia
Hyperplasia and hypertrophy
Enzyme function
Lipid-lowering medications: Statins
Miscellaneous lipid-lowering medications
Laxatives and cathartics
Protein synthesis inhibitors: Aminoglycosides
Antituberculosis medications
Protein synthesis inhibitors: Tetracyclines
Miscellaneous protein synthesis inhibitors
DNA synthesis inhibitors: Metronidazole
Mechanisms of antibiotic resistance
Antimetabolites: Sulfonamides and trimethoprim
Miscellaneous cell wall synthesis inhibitors
Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
Herpesvirus medications
Acetaminophen (Paracetamol)
Antihistamines for allergies
Anatomy of the pharynx and esophagus
Anatomy of the salivary glands
Gallbladder histology
Stomach histology
Colon histology
Pancreas histology
Esophagus histology
Small intestine histology
Liver histology
Gastrointestinal system anatomy and physiology
Liver anatomy and physiology
Anatomy and physiology of the teeth
Enteric nervous system
Gastric motility
Esophageal motility
Chewing and swallowing
Pancreatic secretion
Prebiotics and probiotics
Bile secretion and enterohepatic circulation
Eosinophilic esophagitis (NORD)
Gastric cancer
Celiac disease
Short bowel syndrome (NORD)
Ulcerative colitis
Crohn disease
Gallstone ileus
Familial adenomatous polyposis
Colorectal polyps
Irritable bowel syndrome
Diverticulosis and diverticulitis
Jaundice
Hemochromatosis
Cirrhosis
Cholestatic liver disease
Esophagitis: Clinical
Esophageal disorders: Pathology review
BRUE, ALTE, and SIDS: Clinical
MEN syndromes: Clinical
Abdominal pain: Clinical
Hypertensive disorders of pregnancy: Clinical
Cyclic vomiting syndrome (NORD)
Eating disorders: Clinical
Gastroesophageal reflux disease (GERD)
Gastroesophageal reflux disease (GERD): Clinical
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Esophageal disorders: Clinical
Acid reducing medications
Lipid-lowering medications: Fibrates
Minimal change disease
Non-alcoholic fatty liver disease
Fatty acid synthesis
Fatty acid oxidation
Deep vein thrombosis and pulmonary embolism: Pathology review
Childhood nutrition and obesity: Information for patients and families (The Primary School)
Hunger and satiety
Gallstones
Inflammatory bowel disease: Pathology review
Chronic pancreatitis
Glucagon
Cell membrane
Insulin
Niemann-Pick disease types A and B (NORD)
Metabolic acidosis
Ketone body metabolism
Chronic cholecystitis
Acute cholecystitis
Ascending cholangitis
Pancreatitis: Pathology review
Pancreatitis: Clinical
Bowel obstruction
Jaundice: Pathology review
Gallbladder disorders: Pathology review

Transcript

Watch video only

Content Reviewers

Contributors

The discovery of antibiotics is one of the most important advancements in clinical medicine and public health. It has laid the foundation for a number of other advancements including the ability to perform surgeries more safely and reduction of infant and maternal mortality rates.

Many antibiotics are derived from other bacteria or fungi. For example, penicillin, secreted by the fungus Penicillium, can kill bacteria.

This is because microbes use antibiotics to fight off other microbes. But the use of antibiotics, and, more broadly, antimicrobials, which includes medications that target not only bacteria, but also viruses and fungi, has exploded in recent years.

Antimicrobials have been used on an industrial scale, partially because of overprescription in humans, but more so because of routine use in farm animals!

In fact, a good number of antimicrobials are excreted from humans and animals unchanged, and these get flushed into waste water, which allows pathogens to be perpetually exposed to antimicrobials. In response to this enormous selective pressure, many pathogens have become highly resistant to antimicrobials.

Now when it comes to bacteria, generally speaking, there are four mechanisms for how they become resistant to antimicrobials.

The first mechanism is antibiotic inactivation or modification, which is where bacteria develop specific enzymes that destroy and inactivate antimicrobials.

One example is beta lactamase, which is a bacterial enzyme that destroys antimicrobials that contain a beta lactam ring, like penicillins and cephalosporins. As a result, bacteria that produce beta lactamases are immune to the action of many beta lactam antibiotics.

The second mechanism is the alteration of a target, or binding site. An antibiotic that cannot bind anywhere is rendered useless.

Key Takeaways

The mechanisms of antibiotic resistance can be broadly classified into four categories. First, there is enzymatic modification of the antibiotic includes beta-lactamases, which cleave the beta-lactam ring in penicillins and cephalosporins, and other (e.g. AmpC) enzymes, which hydrolyze most beta-lactams except.

The second mechanism of antibiotic resistance is alteration of the target site on the bacterial cell wall. This involves the production of altered penicillin-binding proteins (PBP), which decrease the affinity of the antibiotic for its target.

Third, bacteria may use efflux pumps, which prevent a variety of antibiotics from accumulating in the bacteria cell, by pumping them out of the bacterial cell. Finally, since some antibiotics (e.g. sulfonamides) work by inhibiting the synthesis of molecules that are vital to the bacteria survival like folic acid, bacteria may just stop producing these molecules, and scavenge for folic acid from the environment instead.